Edwards Lifesciences Corporation revenue breakdown overview

Edwards Lifesciences Corporation revenue for the last year amounted to 6.00 B USD, the most of which — 4.08 B USD — came from its highest performing source at the moment, Transcatheter Mitral and Tricuspid Therapies, the year earlier bringing 3.63 B USD. The greatest contribution to the revenue figure was made by United States — last year it brought Edwards Lifesciences Corporation 3.51 B USD, and the year before that — 3.13 B USD.